| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Irbinitinib (ARRY-380) |
妥卡替尼 |
937263-43-9 |
详细
|
| J-14 |
J-14 |
1043854-13-2 |
详细
|
| PF-573228 |
6-[(4-((3-(甲磺酰基)苄基)氨基)-5-三氟甲基嘧啶-2-基)氨基]-3,4-二氢-1H-喹啉-2-酮 |
869288-64-2 |
详细
|
| Blu-263 |
Blu263 |
|
详细
|
| Lanraplenib (GS-9876) |
GS-9876 |
1800046-95-0 |
详细
|
| CB-103 |
6-[4-(叔丁基)苯氧基]吡啶-3-胺 |
218457-67-1 |
详细
|
| LACS-13909 |
4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl- |
2160546-07-4 |
详细
|
| Pexmetinib (ARRY-614) |
PEXMETINIB |
945614-12-0 |
详细
|
| SHP099 |
SHP-099游离 |
1801747-42-1 |
详细
|
| GSK046 |
VERDINEXOR |
2474876-09-8 |
详细
|
| CDKI-73 |
CS-2259 |
1421693-22-2 |
详细
|
| DGY-06-116 |
DGY-06-116 |
2556836-50-9 |
详细
|
| IM156 |
IM156 |
1422365-93-2 |
详细
|
| Lasmiditan hydrochloride |
613677-28-4 |
613677-28-4 |
详细
|
| Lasmiditan |
2,4,6-三氟-N-[6-[(1-甲基-4-哌啶基)羰基]-2-吡啶基]苯甲酰胺 |
439239-90-4 |
详细
|
| Ceapin-A7 |
N-(1-(2,4-双(三氟甲基)苄基)-1H-吡唑-4-基)-5-(呋喃-2-基)异恶唑-3-甲酰胺 |
2323027-38-7 |
详细
|
| MRT 68921 dihydrochloride |
2080306-21-2 |
2080306-21-2 |
详细
|
| Elacridar |
依克立达 |
143664-11-3 |
详细
|
| WAY-181187(SAX-187) |
WAY 181187 |
554403-49-5 |
详细
|
| Amifloxacin |
氨氟沙星 |
86393-37-5 |
详细
|
| Compound A |
10MG |
1665301-36-9 |
详细
|
| DM1-SMe |
N2'-去乙酰基-N2'-[3-(甲基二硫基)-1-氧代丙基]美登素 |
138148-68-2 |
详细
|
| 4-ACRYLAMIDOBENZO-18-CROWN-6, 98 |
4-丙烯酰胺苯并-18-冠醚 |
68865-32-7 |
详细
|
| 5-chloro-2,3-dihydro-benzofuran-3-ol |
|
5590-44-3 |
详细
|
| 5-CHLORO-2,3-DIHYDRO-BENZOFURAN-3-YLAMINE |
5-氯-2,3-二氢苯并呋喃-3-胺 |
769-21-1 |
详细
|
| 5-CHLORO-2,3-DIHYDRO-BENZOFURAN-3-YLAMINE HYDROCHLORIDE |
5-氯-2,3-二氢苯并呋喃-3-胺盐酸盐 |
669-45-4 |
详细
|
| Lys-SMCC-DM1 |
Lys-SMCC-DM1 |
1281816-04-3 |
详细
|
| PLX4032 (Vemurafenib) |
维罗非尼 |
918504-65-1 |
详细
|
| EPZ015866,GSK3203591 |
GSK591 (EPZ-015866) |
1616391-87-7 |
详细
|
| UK-371804 |
化合物UK371804 |
256477-09-5 |
详细
|
| MKC3946 |
1093119-54-0 |
1093119-54-0 |
详细
|
| Acebilustat |
阿西鲁司特 |
943764-99-6 |
详细
|
| BDA-366 |
1-[[(2S)-3-(二乙基氨基)-2-羟基丙基]氨基]-4-[[(2S)-2-环氧乙烷基甲基]氨基]-9,10-蒽醌 |
1909226-00-1 |
详细
|
| CPI-637 |
(R)-4-甲基-6-(1-甲基-3-(1-甲基-1H-吡唑-4-基)-1H-吲唑-5-基)-4,5-二氢-1H-苯并[B][1,4]二氮杂-2(3H)-酮 |
1884712-47-3 |
详细
|
| Onatasertib(CC 223,ATG-008) |
CC-223 |
1228013-30-6 |
详细
|
| Grapiprant |
GRAPIPRANT |
415903-37-6 |
详细
|
| ETP-46321 |
CS-2500 |
1252594-99-2 |
详细
|
| CNV 1014802 hydrochloride |
(2S,5R)-5-(4-((2-氟苄基)氧基)苯基)吡咯烷-2-甲酰胺盐酸盐 |
934240-31-0 |
详细
|
| STK16-IN-1 |
化合物STK16-IN-1 |
1223001-53-3 |
详细
|
| Fatostatin A Hydrobromide |
FATOSTATIN |
298197-04-3 |
详细
|
| CP-609754 |
CP-609754 |
1190094-64-4 |
详细
|
| ABT-639 |
ABT-639 |
1235560-28-7 |
详细
|
| GDC-0084 |
GDC-0084 |
1382979-44-3 |
详细
|
| UNC1215 |
(2-(苯氨基)-1,4-亚苯基)双((4-(吡咯烷-1-基)哌啶-1-基)甲酮) |
1415800-43-9 |
详细
|
| PF03274167 |
PF-3274167 |
900510-03-4 |
详细
|
| NVS-PAK1-1 |
NVS-PAK1-1 |
1783816-74-9 |
详细
|
| Motolimod (VTX-2337) |
2-氨基-N,N-二丙基-8-(4-(吡咯烷-1-羰基)苯基)-3H-苯并[b]氮杂-4-甲酰胺 |
926927-61-9 |
详细
|
| SH-4-54 |
SH-4-54 |
1456632-40-8 |
详细
|
| SUN11602 |
化合物SUN 11602 |
704869-38-5 |
详细
|
| CHIR-090 |
CHIR 090 |
728865-23-4 |
详细
|
| PFI-3 |
(2E)-1-(2-羟基苯基)-3-[(1R,4R)-5-(2-吡啶基)-2,5-二氮杂双环[2.2.1]庚-2-基]-2-丙烯-1-酮 |
1819363-80-8 |
详细
|
| MS023 |
N1-甲基-N1-[[4-[4-(异丙氧基)苯基]-1H-吡咯-3-基]甲基]-1,2-乙二胺 |
1831110-54-3 |
详细
|
| Vipadenant(BIIB-014) |
3-(4-氨基-3-甲基苄基)-7-(呋喃-2-基)-3H-[1,2,3]三唑并[4,5-d]嘧啶-5-胺 |
442908-10-3 |
详细
|
| AC 55541 |
(E)-N-(2-(2-(1-(3-溴苯基)亚乙基)肼基)-2-氧代-1-(4-氧代-3,4-二氢邻苯二甲嗪-1-基)乙基)苯甲酰胺 |
916170-19-9 |
详细
|
| MK-4101 |
5-(3,3-二氟环丁基)-3-[4-[4-甲基-5-[2-(三氟甲基)苯基]-4H-1,2,4-三唑-3-基]双环[2.2.2]辛烷-1-基]-1,2,4-恶二唑 |
935273-79-3 |
详细
|
| BAY-876 |
BAY-876 |
1799753-84-6 |
详细
|
| GSK189254A |
6-(3-CYCLOBUTYL-2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPIN-7-YLOXY)-N-METHYLNICOTINAMIDE |
720690-73-3 |
详细
|
| GNE-3511 |
化合物GNE-3511 |
1496581-76-0 |
详细
|
| GPR40 agonist 4 |
2-[[4-[(2'-氯[1,1'-联苯]-3-基)甲氧基]苯基]磺酰基]乙酸 |
2102196-57-4 |
详细
|
| Elacridar hydrochloride |
依克立达盐酸盐 |
143851-98-3 |
详细
|
| Letermovir |
乐特莫韦 |
917389-32-3 |
详细
|
| AM-2394 |
AM2394 |
1442684-77-6 |
详细
|
| MK-3903 |
MK-3903 |
1219737-12-8 |
详细
|
| (±)-BAY-1251152 |
1610358-53-6 |
1610358-53-6 |
详细
|
| ML365 |
ML-365 |
947914-18-3 |
详细
|
| Verinurad |
维立诺雷 |
1352792-74-5 |
详细
|
| HG-10-102-01 |
[4-[[5-氯-4-(甲基氨基)-2-嘧啶基]氨基]-3-甲氧基苯基]-4-吗啉基甲酮 |
1351758-81-0 |
详细
|
| EX229 |
EX229 |
1219739-36-2 |
详细
|
| GSK6853 |
GSK6853 |
1910124-24-1 |
详细
|
| Benzoic acid, |
3-(3-(4-(2,4,4-三甲基戊-2-基)苯氧基)丙酰胺基)苯甲酸甲酯 |
2143473-95-2 |
详细
|
| Opicapone |
奥匹卡朋 |
923287-50-7 |
详细
|
| FIT-039 |
FIT-039 |
1113044-49-7 |
详细
|
| JTE 013 |
JTE-013 |
383150-41-2 |
详细
|
| GSK-843 |
GSK-843 |
1601496-05-2 |
详细
|
| CGP 60474 |
3-((4-(2-((3-氯苯基)氨基)嘧啶-4-基)吡啶-2-基)氨基)丙-1-醇 |
164658-13-3 |
详细
|
| IDO-IN-7(Navoximod) |
IDO-IN-7抑制剂 |
1402837-78-8 |
详细
|
| faldaprevir |
FALDAPREVIR |
801283-95-4 |
详细
|
| Bictegravir |
比克替拉韦 |
1611493-60-7 |
详细
|
| Dasotraline hydrochloride |
达索曲林盐酸盐 |
675126-08-6 |
详细
|
| NIK SMI1 |
NIK SMI1 |
1660114-31-7 |
详细
|
| TRC253 |
CS-2727 |
2110426-27-0 |
详细
|
| JNJ40411813 |
JNJ40411813 |
1127498-03-6 |
详细
|
| JNJ-42165279 |
N-(4-氯-3-吡啶基)-4-[(2,2-二氟-1,3-苯并二恶茂-5-基)甲基]-1-哌嗪甲酰胺 |
1346528-50-4 |
详细
|
| BVT948 |
4-羟基-3,3-二甲基-2H-苯并[G]吲哚-2,5(3H)-二酮 |
39674-97-0 |
详细
|
| TRULI |
1H-Pyrrolo[2,3-b]pyridine-3-carboxamide, N-[3-(phenylmethyl)-2(3H)-thiazolylidene]- |
1424635-83-5 |
详细
|
| PIK-90 |
N-(2,3-二氢-7,8-二甲氧基咪唑并[1,2-C]喹唑啉-5-基)-3-吡啶甲酰胺 |
677338-12-4 |
详细
|
| (E)-3-(2-(1H-tetrazol-5-yl)vinyl)-6-fluoro-1H-indole |
(E)-3-(2-(1H-四氮唑-5-基)乙烯基)-6-氟-1H-吲哚 |
1316695-35-8 |
详细
|
| THZ531 |
THZ531 |
1702809-17-3 |
详细
|
| THZ2 |
THZ2 |
1604810-84-5 |
详细
|
| Dibenzazepine |
二苯并氮卓 |
209984-56-5 |
详细
|
| GDC0575 |
(R)-N-(4-(3-氨基哌啶-1-基)-5-溴-1H-吡咯并[2,3-B]吡啶-3-基)环丙烷甲酰胺 |
1196541-47-5 |
详细
|
| Caroverine HCl |
盐酸卡罗维林 |
55750-05-5 |
详细
|
| BI-3406 |
N-((R)-1-(3-氨基-5-(三氟甲基)苯基)乙基)-7-甲氧基-2-甲基-6-(((S)-四氢呋喃-3-基)氧基)喹唑啉-4-胺 |
2230836-55-0 |
详细
|
| A-966492 |
A-966492 |
934162-61-5 |
详细
|
| Fevipiprant |
非维匹仑 |
872365-14-5 |
详细
|
| Siramesine HCl |
西拉美新盐酸盐 |
224177-60-0 |
详细
|
| ACTB-1003 |
N-[4-[4-氨基-6-(甲氧基甲基)-7-(4-吗啉基甲基)吡咯并[2,1-f][1,2,4]三嗪-5-基]-2-氟苯基]-N'-[2-氟-5-(三氟甲基)苯基]脲 |
939805-30-8 |
详细
|
| MRTX-1257 |
MRTX-1257 |
2206736-04-9 |
详细
|
| AT-527 |
L-Alanine, N-[[P(S),2'R]-2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-P-phenyl-5'-adenylyl]-, 1-methylethyl ester |
1998705-64-8 |
详细
|
| Darexaban |
N-[2-羟基-6-(4-甲氧基苯甲酰氨基)苯基]-4-(4-甲基-1,4-二氮杂庚烷-1-基)苯甲酰胺 |
365462-23-3 |
详细
|